Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Low inspired oxygen concentration (FiO₂=50%) during one-lung ventilation: Ventilation with initial FiO₂=50% during one-lung ventilation, combined with individualized PEEP titration. Oxygen concentration is dynamically adjusted based on SpO₂; ventilation duration at each FiO₂ level and total oxygen exposure burden are recorded.
High inspired oxygen concentration (FiO₂=100%) during one-lung ventilaion: Ventilation with FiO₂=100% throughout one-lung ventilation, combined with individualized PEEP titration (decremental PEEP titration selecting the highest PEEP corresponding to the lowest driving pressure).
Study summary
This study aims to investigate whether using 50% FiO₂ during one-lung ventilation, compared with 100% FiO₂, reduces postoperative atelectasis in the non-dependent (healthy) lung of patients undergoing VATS pulmonary lobectomy, based on individualized PEEP titration. This is a single-center, prospective, assessor- and patient-blinded randomized controlled trial. A total of 100 patients (50 per group, including a pilot phase of 10 per group) will be enrolled and randomized 1:1 to the high-oxygen group (FiO₂=100%) and the low-oxygen group (FiO₂=50%). The primary endpoint is the percentage of atelectasis volume in the non-operated lung relative to the total non-operated lung volume, assessed by CT at 60±10 minutes after tracheal extubation.
Eligibility
Primary outcome measure(s)
- Non-operated lung atelectasis volume percentage — CT scans were performed at 60 ± 10 minutes after tracheal extubation to assess the volume ratio of atelectasis in the contralateral lung.
Chest CT at 60±10 minutes after tracheal extubation
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Anesthesiology, Peking University People's Hospital | Beijing | Beijing Municipality |
More Peking University People's Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07721558 on ClinicalTrials.gov ↗ ← All trials in China